Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob Ter Heine

Showing results (111-120 of 160) with videos related to

Pageof 16
Sort By:
Nuklearmedizin. Nuclear Medicine|July 23, 2016
Treatment of painful bone metastases in prostate and breast cancer patients with the therapeutic radiopharmaceutical rhenium-188-HEDP. Clinical benefit in a real-world studyRogier Lange, Floor Overbeek, John M H de Klerk, et al.
AIDS (London, England)|February 3, 2022
HIV-1 pretreatment drug resistance negatively impacts outcomes of first-line antiretroviral treatmentLucas E Hermans, Laura M Hofstra, Rob Schuurman, et al.
British Journal of Cancer|June 11, 2024
Proactive monitoring of drug-drug interactions between direct oral anticoagulants and small-molecule inhibitors in patients with non-small cell lung cancerJudith L Gulikers, Leila-Sophie Otten, Lizza E L Hendriks, et al.
BMC Medicine|November 7, 2024
Azithromycin in severe malaria bacterial co-infection in African children (TABS-PKPD): a phase II randomised controlled trialRoisin Connon, Peter Olupot-Olupot, Arthur M A Pistorius, et al.
Clinical Pharmacokinetics|March 10, 2018
A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant WomenStein Schalkwijk, Rob Ter Heine, Angela C Colbers, et al.
Pediatric Nephrology (Berlin, Germany)|October 31, 2018
The potential impact of hematocrit correction on evaluation of tacrolimus target exposure in pediatric kidney transplant patientsAnne M Schijvens, Fransje H S van Hesteren, Elisabeth A M Cornelissen, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 12, 2022
Posaconazole bioavailability of the solid oral tablet is reduced during severe intestinal mucositisAnouk M E Jansen, Eline W Muilwijk, Walter J F M van der Velden, et al.
The Journal of Antimicrobial Chemotherapy|August 31, 2021
High unbound flucloxacillin fraction in critically ill patientsEveline Wallenburg, Rob Ter Heine, Dylan W de Lange, et al.
AIDS (London, England)|August 11, 2022
A randomized study of intensified antiretroviral treatment monitoring versus standard-of-care for prevention of drug resistance and antiretroviral treatment switchLucas E Hermans, Rob Ter Heine, Rob Schuurman, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 3, 2022
Proposal for individualized dosing of eculizumab in atypical haemolytic uraemic syndrome: patient friendly and cost-effectiveMendy Ter Avest, Romy N Bouwmeester, Caroline Duineveld, et al.
Pageof 16

Showing results (111-120 of 160) with videos related to

Sort By:
Pageof 16
Nuklearmedizin. Nuclear Medicine|July 23, 2016
Treatment of painful bone metastases in prostate and breast cancer patients with the therapeutic radiopharmaceutical rhenium-188-HEDP. Clinical benefit in a real-world studyRogier Lange, Floor Overbeek, John M H de Klerk, et al.
AIDS (London, England)|February 3, 2022
HIV-1 pretreatment drug resistance negatively impacts outcomes of first-line antiretroviral treatmentLucas E Hermans, Laura M Hofstra, Rob Schuurman, et al.
British Journal of Cancer|June 11, 2024
Proactive monitoring of drug-drug interactions between direct oral anticoagulants and small-molecule inhibitors in patients with non-small cell lung cancerJudith L Gulikers, Leila-Sophie Otten, Lizza E L Hendriks, et al.
BMC Medicine|November 7, 2024
Azithromycin in severe malaria bacterial co-infection in African children (TABS-PKPD): a phase II randomised controlled trialRoisin Connon, Peter Olupot-Olupot, Arthur M A Pistorius, et al.
Clinical Pharmacokinetics|March 10, 2018
A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant WomenStein Schalkwijk, Rob Ter Heine, Angela C Colbers, et al.
Pediatric Nephrology (Berlin, Germany)|October 31, 2018
The potential impact of hematocrit correction on evaluation of tacrolimus target exposure in pediatric kidney transplant patientsAnne M Schijvens, Fransje H S van Hesteren, Elisabeth A M Cornelissen, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 12, 2022
Posaconazole bioavailability of the solid oral tablet is reduced during severe intestinal mucositisAnouk M E Jansen, Eline W Muilwijk, Walter J F M van der Velden, et al.
The Journal of Antimicrobial Chemotherapy|August 31, 2021
High unbound flucloxacillin fraction in critically ill patientsEveline Wallenburg, Rob Ter Heine, Dylan W de Lange, et al.
AIDS (London, England)|August 11, 2022
A randomized study of intensified antiretroviral treatment monitoring versus standard-of-care for prevention of drug resistance and antiretroviral treatment switchLucas E Hermans, Rob Ter Heine, Rob Schuurman, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 3, 2022
Proposal for individualized dosing of eculizumab in atypical haemolytic uraemic syndrome: patient friendly and cost-effectiveMendy Ter Avest, Romy N Bouwmeester, Caroline Duineveld, et al.
Pageof 16